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Abstract
We consider nonparametric inference for event time distributions based on current
status data. We show that in this scenario conventional mixture priors, including the
popular Dirichlet process mixture prior, lead to biologically uninterpretable results as
they unnaturally skew the probability mass for the event times toward the extremes of
the observed data. Simple assumptions on dependent censoring can fix the problem.
We then extend the discussion to bivariate current status data with partial ordering of
the two outcomes. In addition to dependent censoring, we also exploit some minimal
known structure relating the two event times. We design a Markov chain Monte
Carlo algorithm for posterior simulation. Applied to a recurrent infection study, the
method provides novel insights into how symptoms-related hospital visits are affected
by covariates.
Key Words: Survival regression; Current status data; Bayesian nonparametrics;
Joint modeling; Race model; Recurrent infections
Short/Running Title: Bivariate Survival Regression
Corresponding Author: Giorgio Paulon (giorgio.paulon@utexas.edu)
ar
X
iv
:2
00
9.
06
46
0v
1 
 [s
tat
.M
E]
  1
4 S
ep
 20
20
1 Introduction
We develop Bayesian nonparametric survival regression for bivariate event times that
are subject to a single censoring time. In particular, we consider bivariate current
status data (Groeneboom and Wellner, 1992), referring to situations where the only
available information on each event time is whether or not it exceeds a monitoring
time that is common to the two outcomes. Data of this type are often collected
in studies on the prevalence of recurrent infectious diseases. We show that standard
survival analysis models (Ibrahim et al., 2001) fail to provide a meaningful estimate of
the latent event time distribution when applied to current status data. The analysis
of this kind of data is complicated by the fact that all event times are either left
or right censored. We propose a modeling approach that addresses this gap in the
literature.
Our goal is to develop a flexible model whose parameters have a biologically
meaningful interpretation. Bayesian models are especially useful in such scenarios
because of their ability to accommodate prior information. Nonparametric priors are
often used to flexibly model a baseline survival function, usually completed with a
parametric component that relates survival to a number of predictors. For example,
extensions of the proportional hazards (PH) model (Cox, 1972) have been proposed
in Kalbfleisch (1978) and in Hjort et al. (1990). Generalizations of the accelerated
failure times (AFT) model (Buckley and James, 1979) based on a Dirichlet process
prior appear in Christensen and Johnson (1988), Kuo and Mallick (1997), Kottas and
Gelfand (2001), Hanson and Johnson (2004), or alternatively using Polya trees, for
example in Hanson and Johnson (2002). In other cases the main inference target is
the hazard function. Sparapani et al. (2016), for instance, construct nonparametric
survival regression using a Bayesian additive regression tree (BART) model (Chipman
et al., 2010) by adding time as an ordinal predictor to a BART-probit model for the
hazard function.
In general, censored observations contribute limited information, via the distribu-
tion function or survival function as the corresponding factors of the joint likelihood.
This becomes problematic in the case of current status data, as we shall demonstrate.
Some proposals have been put forward to tackle these issues. In the case of survival
regression, generalizations of the PH model for current status data have been intro-
duced in Cai et al. (2011) and in Wang et al. (2015), focusing on the univariate case.
More similar to our approach, Wang and Ding (2000) model dependence between
bivariate event times via a copula function. Dunson and Dinse (2002) use a Bayesian
probit model with normal frailties to induce dependence among multivariate cur-
rent status data. Nevertheless, there remains a gap in the literature concerning fully
nonparametric regression for bivariate current status data with dependent censoring.
The motivating case study is inference for the Partner Notification Study (Golden
et al., 2005). The goal of the study is to understand the times of development of
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infection and symptoms for recurrent episodes of gonorrhea and/or chlamydial infec-
tions. The study design includes a single follow-up visit for each individual. During
this visit the presence of symptoms and infection was recorded, leading to all censored
data with shared censoring times for the two outcomes.
Let S denote the time of the onset of symptoms, I the time of infection, and C
the time of the hospital visit. Thus, four responses are possible: presence of both
disease and symptoms (I < C, S < C), absence of both (I > C, S > C), absence of
symptoms and presence of disease (I < C, S > C), and symptoms without disease
(I > C, S < C). The latter can be explained by the fact that the surveyed symptoms
are very generic and might also arise due to other underlying causes. This setup
yields data that are bivariate in nature as two outcomes are registered. However, the
censoring times, i.e. the hospital visit times, are restricted to a lower dimensional
subspace, with a single follow-up visit to assess the presence of both symptoms and
disease. Additional complexity arises from the partial ordering of the two outcomes:
the infection time is a priori unlikely to follow the symptoms time. This can only
occur when the symptoms arise due to other causes. Our model introduces features to
reflect this consideration. We use a mixture model with one submodel being subject
to an order constraint, representing symptoms due to the infection of interest, and
another submodel without such constraint, allowing for symptoms due to other causes.
While our discussion is motivated by a specific application, we note that similar data
formats arise frequently in any study that involves data collection during follow-up
visits. For example, doctors might record tumor recurrence using a CT scan and
symptoms as reported by patients.
In the first part of this article, we demonstrate with simple examples the problems
arising from the use of standard techniques with current status data. We then intro-
duce structural assumptions that allow us to identify a meaningful distribution of the
latent bivariate outcomes. We propose a Bayesian nonparametric (BNP) approach
for modeling the joint distribution under these assumptions. An important feature
of BNP models is their large support, allowing us to approximate essentially arbi-
trary distributions (Ishwaran and James, 2001). To handle covariates, our approach
is based on the dependent Dirichlet process (DDP) prior introduced by MacEach-
ern (1999). See also the discussion in De Iorio et al. (2004) for the special case of
categorical covariates.
The rest of this article is organized as follows. Section 2 describes the clinical
study that motivates this article. Section 3 develops the proposed inference approach
starting from a simple univariate case. Section 4 uses the univariate model as a
building block for bivariate outcomes. Section 5 outlines computational challenges
and an MCMC strategy. Section 6 presents the results of the proposed method
applied to the Partner Notification Study. Section 7 finishes with concluding remarks.
Additional details, including proofs, the MCMC scheme, convergence diagnostics and
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simulation studies are deferred to the supplementary materials.
2 The Partner Notification Study
The Partner Notification Study (Golden et al., 2005) enrolled men and women who
received a diagnosis of gonorrhea or genital chlamydia at most 14 days prior to en-
rollment. It was conducted in King County Seattle (Washington state, U.S.A.) from
September 1998 to March 2003. Researchers contacted clinicians who diagnosed and
treated the infections to seek permission to contact their patients. To minimize the
likelihood of reinfection before randomization, patients who could not be contacted
within 14 days after treatment were not eligible for the study, yielding a total of
n = 1864 participants. The study was designed to gather current status data of
recurrent gonorrhea or chlamydial infection in patients 3 to 19 weeks after random-
ization to standard (control group, 933 individuals) or expedited partner therapy
(intervention group, 931 individuals). The primary outcome was persistent or recur-
rent gonorrhea and/or chlamydial infection in the original participants within 90 days
after enrollment, although actual follow up times varied considerably (19 to 161 days)
due to difficulty contacting participants and scheduling follow-up visits.
When visiting the hospital, two outcomes were recorded for each patient: presence
of an infection (Ii) and of symptoms (Si). Thus, two latent event times (Ii, Si)
correspond to a common censoring time Ci, i.e. the time of the hospital visit. The
data record for each patient Ci, and whether the patient has already experienced the
infection ∆Ii = 1(Ii < Ci) and some symptoms ∆Si = 1(Si < Ci). While in general
symptoms should follow the onset of infection, the definition of symptoms in this
study is very generic and they might also be due to other causes. In the case Ii < Si
it is impossible to tell whether symptoms are due to the disease of interest or any
other cause, while when Ii > Si the symptoms are known to be due some other cause.
The recorded n = 1832 follow-up visits included patients reporting all four pos-
sible combinations of censoring for the two outcomes: n00 = 1303 patients did not
experience symptoms and tested negative for the infection; n10 = 121 patients tested
positive for the infection but were not experiencing any symptoms (asymptomatic
infections); n01 = 325 patients tested negative for the infection but were experiencing
symptoms (due to other causes); n11 = 83 patients tested positive for the infection
and were also experiencing symptoms (symptomatic infections).
Figure 1 shows two univariate nonparametric maximum likelihood estimates
(MLE) (Groeneboom and Wellner, 1992) for the distributions of time to infection
Ii and time to symptoms Si, stratified by two covariates (gender and intervention).
Female participants seem to experience symptoms sooner than men. The flat region
of survival probability in the middle of the range of the observed data is due to the
limited assumptions of the nonparametric MLE and is clinically highly implausible.
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In Section 3 we show that the accumulation of probability mass toward the bounds
of the observation range is a common issue when dealing with current status data.
Moreover, these nonparametric MLE estimates represent marginal effects and do not
take into account any correlation that is expected between the time to infection and
the time to development of symptoms.
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Figure 1: Nonparametric MLE estimate for infection times (left panel) and time until
symptoms (right panel), stratified by the binary covariates gender and treatment
fixing age to the average age in the sample.
3 Univariate Survival Analysis for Current Status
Data
We introduce a Bayesian nonparametric (BNP) modeling strategy for current status
data, first in a simple univariate case. First, we show that the nonparametric MLE
for current status data has an undesirable feature that makes it biologically uninter-
pretable. Most of the probability mass is accumulated toward the extremes of the
data range.
Let Si represent the latent event time for patient i, ∆i be a censoring indicator
with ∆i = 1 if the event has been detected and ∆i = 0 otherwise , and let Ci denote
the censoring time. That is, when ∆i = 1, then Si ≤ Ci (left censored), otherwise
Si > Ci (right censored). We want to infer the unknown distribution fS(s) based on
only the observed censoring times and indicators (Ci,∆i), i = 1, . . . , n.
3.1 Limitations of the Maximum Likelihood Estimator
We show that under moderate sample sizes the nonparametric MLE does not provide
meaningful estimates of the latent time distribution for current status data. Without
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loss of generality, we assume that the censoring times are ordered, Ci ≤ Ci−1, and
that ∆1 = 1,∆n = 0. Define A = {i > 1 s.t. ∆i = 1,∆i−1 = 0} ∪ {1} as the
set of indices of left censored observations immediately following a right censored
observation, i.e. the set of indices of the pairs (∆i−1,∆i) = (0, 1). Next, let J = |A|
and C? = (C?1 , . . . , C
?
J) = (Ci, i ∈ A) denote the corresponding censoring times. See
Figure 2 for an illustration.
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Figure 2: An example with n = 12 latent event times. The set of support points is
A = {1, 4, 7, 10}. On the x-axis, 0 and 1 indicate the values of ∆i.
Let C?J+1 denote any point to the right of the last right censored observation. The
times C? ∪ {C?J+1} are the only points where probability mass can accumulate under
the nonparametric MLE. In other words, the support of a discrete nonparametric
density estimate for the latent event times can have probability mass only at the left
censoring times. More specifically, at (i) the left censored observation in every “01”
pair, (ii) the first left censored observation, and (iii) any point to the right of the last
right censored observation. To see this, write the unknown distribution fS(·) of the
latent times Si as a discrete probability measure with atoms at the C
?
j , i.e.
fS(s) =
J+1∑
j=1
pjδC?j . (1)
We denote with Fj =
∑
k≤j pk the cumulative density function (c.d.f.) and with
F¯j = 1−Fj the survival function at the support points. To see that the nonparametric
MLE for fS(s) can only have support on the set C
?, assume that fS(s) were to include
any additional probability mass p at Ci 6= C?j , j = 1, . . . , J . Let j? = maxj{C?j < Ci}
and j′ = minj{C?j > Ci} denote the point mass in C? closest to Ci from the left and
from the right, respectively. Then, if ∆i = 1 one could move the probability mass p
to C?j? , and if ∆i = 0 one could move the probability mass p to C
?
j′ . Either would
leave the likelihood function unchanged.
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Groeneboom and Wellner (1992) introduce a simple EM algorithm to estimate the
unknown c.d.f for the latent times. Let lj = #{Ci s.t. ∆i = 1, C?j ≤ Ci < C?j+1} and
rj = #{Ci s.t. ∆i = 0, C?j < Ci ≤ C?j+1} denote the runs of left and right censored
observations, respectively. Let Y = {(Ci,∆i)}ni=1 denote the data. The log-likelihood
function under model (1) is
`(p; Y) =
n∑
i=1
{δ1(∆i) · logF (Ci) + δ0(∆i) · logF¯ (Ci)}
=
J∑
j=1
{ljlogFj + rjlogF¯j}.
If instead we knew the latent times z = {Si}ni=1, we could use the full data log-
likelihood `(p, z) =
∑J
j=1 njlog(pj) where nj = #{Si = C?j }. The expectation of this
full data log-likelihood with respect to z involves only E(nj | p). This motivates an
easy Expectation Maximization (EM) algorithm, shown in Algorithm 1.
Algorithm 1 (Expectation Maximization)
E-step
1: For given p = p(t), evaluate the expectation of the nj’s w.r.t. the latent censored
event times. This involves distributing lj to all C
?
j′ , j
′ ≤ j with weights pj′/Fj;
and rj to all C
?
j′ , j
′ > j with weights pj′/F¯j, i.e.
n˜j = Es[nj | p] =
∑
h≤j
lhpj/Fh +
∑
h>j
rhpj/F¯h.
M-step
2: Replacing the unknown nj’s with their expectations n˜j makes the maximization
(w.r.t p) of the expected (w.r.t z) full data log-likelihood `(p, z) straightforward,
yielding the update
p
(t+1)
j = n˜j/n.
We illustrate the algorithm on simulated data with n = 200 latent times gener-
ated from a mixture of three normal distributions with weights pi = (0.4, 0.2, 0.4)ᵀ,
locations µ = (20, 40, 60)ᵀ and scale parameters σ2 = (25, 25, 25)ᵀ. The censoring
times Ci were simulated according to model (2), defined below. As shown in Figure
3a, despite a large number of support points C?, in this simulation study most of the
probability mass under the unconstrained MLE accumulates close to the bounds of
the range of the data. One might conjecture that the issue is caused by the exces-
sively flexible nature of the unconstrained MLE. However, even parametric models
fail to capture the underlying distribution of the latent times. For comparison, we
6
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Figure 3: Simulated data. Right and left censoring times are represented by black
“0” and red “1”, respectively, on the x-axis.
carried out inference using a mixture of K = 3 Gaussian distributions for the latent
times S, matching the actual simulation truth. In Figure 3b, we show the posterior
mean for the unknown event time distribution under this model when fitted to the
current status data in the simulation study. The posterior estimated distribution still
allocates most probability mass toward the extremes of the data, despite using an
analysis model that matched the actual simulation truth.
3.2 A Bayesian Nonparametric Model
We introduce some assumptions to address the issues described in the previous section.
In short, we regularize the model by (i) explicitly modeling the dependence between
censoring times and latent event times, and (ii) introducing prior shrinkage with a
flexible Bayesian nonparametric prior.
Knowledge about dependent censoring allows us to gain some information on fS(·)
from the censoring times. For example, in the motivating case study it is expected
that patients seek help shortly after they experience symptoms. This information can
be incorporated in the model in many ways. For our specific application, we assume
that the censoring times Ci’s arise from a race between a return by schedule versus a
return driven by the onset of symptoms, as
Ci | Si, λ = min{Si + Exp(λ); Unif(A,B)}, (2)
where A and B represent the range of the observation window, and Exp(λ) and
7
Unif(A,B) refer to random variables with the respective distribution. In other words,
the visit time to the hospital can either occur uniformly in the observation range
(visit by protocol) or it can closely follow the symptoms onset (visit prompted by
symptoms). The resulting distribution is easily evaluated.
Lemma 1. The p.d.f. of the conditional distribution of censoring times given the
event times is given by
fC|S(c | s) = 1{c ≤ s}
B − A +
1{c > s}
B − A e
−λ(c−s){1 + λ(B − c)}.
In addition to exploiting dependence, specifying a Bayesian nonparametric prior
for the latent event time also helps to regularize inference on fS(·). Relaxing para-
metric assumptions allows for greater modeling flexibility, robustness against mis-
specification of a parametric statistical model and, as a result, more honest un-
certainty assessment. At the same time, prior smoothing and shrinkage result in
more realistic and clinically meaningful estimates. In addition, a BNP model can
allow to accommodate heterogeneous patient populations, for example using the
Dirichlet process (DP) prior. The DP was originally introduced by Ferguson (1973)
and can be defined from its finite-dimensional analog. We write H ∼ DP (M,H0)
if the random distribution H is such that for any partition A1, . . . , AK of the
sample space the random vector of the H(Ai) follows a Dirichlet distribution,
(H(A1), . . . , H(AK)) ∼ Dir{MH0(A1), . . . ,MH0(AK)}. The DP prior is indexed
by the total mass parameter M (which controls the variance) and by the cen-
tering measure H0 (which defines the expectation). In fact, E[H(A)] = H0(A)
and Var[H(A)] = H0(A){1 − H0(A)}/(M + 1). Alternatively, Sethuraman (1994)
gives a constructive definition for the DP, known as the stick-breaking construction:
H =
∑+∞
k=1 pikδθk with pik = νk
∏
l<k(1− νl), νk iid∼ Beta(1,M) and θk iid∼ H0. In partic-
ular, the DP generates almost surely discrete probability measures. For this reason,
often an additional convolution with a continuous kernel k(y | θ) is used to repre-
sent a random probability measure F =
∫
k(y | θ)dH(θ) = ∑+∞k=1 pikk(y | θk) with
H ∼ DP (M,H0). The model is known as DP mixture (DPM). Two natural choices
of sampling models for survival data are the log normal and the Weibull families. In
applications with event times close to 0, it can be convenient to first log transform
the data and then use normal kernels, i.e. use log normal kernels. In many instances,
however, a mixture of normals may suffice (Lo, 1984) and is often preferred.
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The BNP-CS model
The resulting model can be summarized as follows
Ci | Si, λ = min{Si + Exp(λ); Unif(A,B)}
Si | H ∼
∫
N(Si | µ, σ2)dH(µ, σ2), H ∼ DP(M,H0).
(3)
The model is completed with hyperpriors, including
H0 = N(µk | µ0, σ2k/κ0)× IG(σ2k | aσ, bσ),
M ∼ Gamma(aM , bM) and λ ∼ Gamma(aλ, bλ). Using the stick-breaking construc-
tion of the DP, the second line of model (3) can be rewritten as
Si | {µk, σ2k, pik}+∞k=1 ∼
+∞∑
k=1
pikN(Si | µk, σ2k)
with (µk, σ
2
k) ∼ H0, i.i.d., and pi ∼ SB(M), where SB(M) denotes the stick-breaking
construction for the weights, with concentration parameter M . In our implementa-
tion, we also use priors on the hyperparameters µ0, κ0, bσ. We refer to (3) as BNP
for current status (BNP-CS) model, with the name implying that alternative BNP
priors other than the DPM (see, e.g. Mu¨ller et al., 2015) could be used if desired.
Inference under the BNP-CS model for the same data used in the illustration of
Section 3.1 recovers the underlying truth better than inference under the model of
the simulation truth. Figure 4 shows the survival function estimated under (i) an
unconstrained nonparametric model estimated by the EM algorithm, (ii) a mixture
of K = 3 normal distributions, and (iii) the proposed nonparametric model with
dependent censoring. Although the model under (ii) matches the simulation truth,
both, (i) and (ii) fail to recover a meaningful estimate, while inference under (iii)
successfully exploits the information that is contained in the observed Ci.
9
0000000000000000000000000000000000 000000 00000 00 011111111111111111111111 11111111111111 1111111111 10.00
0.25
0.50
0.75
1.00
0 20 40 60 80
S
F S
(s)
Figure 4: Simulated data: Right and left censoring times are represented by “0” and
“1”, respectively, on the x-axis. The green step function shows an estimate of the
survival function under the nonparametric MLE. The blue curve shows an estimate
of the survival function under a mixture of normals model (the simulation truth).
The red curve shows an estimate of the survival function under the proposed model.
Shaded areas represent pointwise 95% credible intervals for the estimated survival
functions. The black dashed line represents the simulation truth.
4 Bivariate Survival Regression for Partially Or-
dered Current Status Data
4.1 A Bivariate Event Time Model
We now use the BNP-CS model (3) as a building block for bivariate outcomes. Beyond
the already discussed dependence of Si and Ci, we add some more structure based on
prior knowledge of the underlying process. We introduce a mixture model to reflect
that patients can experience the symptoms due to the disease of interest or they can
arise from other causes, in which case we assume independence in the corresponding
submodel. That is, we model the bivariate event time distribution fIS(I, S) of time
to infection and time to symptoms as a mixture model in which one of the two
components is subject to the order constraint I < S. This translates to
fIS(I, S) = wf
?
IS(I, S) + (1− w)f ′IS(I, S) (4)
where f ′IS(I, S) is subject to I < S, whereas f
?
IS(I, S) is not. Therefore, f
?
IS(I, S)
can be interpreted as the distribution of (I, S) for a patient with symptoms “due to
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other causes”. Figure 5 shows the support of the two components of the mixture as
well as the support for the latent times corresponding to the four possible censoring
indicators.
I
S
(a){Ii > Ci, Si > Ci}
(Ci, Ci)
(Cj, Cj)
I
S
(b){Ii > Ci, Si ≤ Ci}
(Ci, Ci)
I
S
(c){Ii ≤ Ci, Si ≤ Ci}
(Ci, Ci)
(Cj, Cj)
I
S
(d){Ii ≤ Ci, Si > Ci}
(Ci, Ci)
(Cj, Cj)
Figure 5: Domain of the data (I > 0, S > 0) and support for the latent times
corresponding to the four cases. The gray quadrants represent the support for the
latent times corresponding to the observed censoring times (Ci, Ci) under f
?
IS(I, S).
The area with red horizontal lines represents the support for the latent times under
f ′IS(I, S).
We make two main assumptions: (i) under f ?IS(I, S), the time to symptoms (due to
other causes) and time to infection are independent; (ii) under f ′IS(I, S), the latency
time L = S − I and the time to infection are independent. Here L is the delay from
the onset of illness to the development of symptoms. The assumed marginal fI(·) on
I is shared by both, f ?IS and f
′
IS. Thus, model (4) becomes
fIS(I, S) = wfI(I)f
?
S(S) + (1− w)fI(I)fL(S − I). (5)
For later reference we note that sampling, (Ii, Si) ∼ fIS can be equivalently written
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as a hierarchical model with latent indicators, say r
(W )
i with p(r
(W )
i = 1) = w and
(Ii, Si | r(W )i ) ∼
fI(I)f
?
S(S) if r
(W )
i = 1
fI(I)fL(S − I) if r(W )i = 0.
(6)
The second component in (5) includes the constraint I < S as a positivity con-
straint on the latency time L > 0. Recent approaches to deal with hard constraints
use relaxation methods that replace the hard constraint with priors that penalize de-
partures outside of the constraint subspace (Duan et al., 2020). Alternatively, Patra
and Dunson (2018) developed methodology that uses unconstrained inference and
then projects the posterior draws onto the constrained subspace. In our model, as-
signing positive support to the reparametrized variable L automatically ensures the
required order constraint I < S. In the following, we will use L | λL ∼ Exp(λL). As
a consequence, under the component f ′IS(I, S) = fI(I)fL(S − I), time to symptoms
and time to infection are dependent.
We highlight our use of structural model assumptions that reflect prior knowl-
edge of the biology behind current status data for infectious diseases. In partic-
ular, as discussed thoroughly in Wang and Ding (2000), the joint distribution for
bivariate current status data is not likelihood identifiable nonparametrically. Thus,
two approaches are possible: (i) estimate the joint distribution under parametric or
semiparametric assumptions, or (ii) build the joint model from the two identifiable
marginal distributions and a particular choice for their dependence structure. This
article uses the latter strategy.
4.2 Bayesian Nonparametric Priors
The model is completed by introducing priors for the two unknown distributions,
assuming nonparametric mixture models for both fI(I) and f
?
S(S),
fI(I) =
∫
N(I | θ(I))dH(I)(θ(I)) =
+∞∑
k=1
pi
(I)
k N(I | µ(I)k , σ(I)2k )
f ?S(S) =
∫
N(I | θ(S))dH(S)(θ(S)) =
+∞∑
k=1
pi
(S)
k N(S | µ(S)k , σ(S)2k ),
(7)
where θ(I) = (µ(I), σ(I)2) and θ(S) = (µ(S), σ(S)2). Here H(I)(·) = ∑k pi(I)k δθ(I) , and
similarly H(S), are the random mixing measures. The model is completed with a
prior probability model on H(I) and H(S). Prior distributions on random probability
measures are known as nonparametric Bayes (BNP) models.
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Using a nonparametric prior on H(I) and H(S) the model becomes a mixture of
normals with respect to the chosen random mixing measure. For example, in our
implementation we assume a DP prior again, as in (3), now using two instances for
fI and f
?
S. Alternatively, any other nonparametric Bayesian prior (e.g. James et al.,
2009) could be used. The following result gives the marginal distributions implied by
our construction.
Theorem 1. The marginal distributions implied by model (5) with priors (7) are
fI(I) =
+∞∑
k=1
pi
(I)
k N(I | µ(I)k , σ(I)2k )
fS(S) = w
+∞∑
k=1
pi
(S)
k N(S | µ(S)k , σ(S)2k ) + (1− w)
+∞∑
k=1
pi
(I)
k EMG(S | µ(I)k , σ(I)2k , λL),
where EMG(µ, σ2, λ) denotes the exponentially modified Gaussian distribution (Grushka,
1972).
Model (5) together with (7) and (3) for p(Ci | Si) defines the proposed bivariate
BNP-CS model for current status data.
One of the reasons for the wide use of BNP mixtures like (7) is the induced prior
on a random partition. Consider Ii ∼ fI , i = 1, . . . , n. Under model (7) we can
introduce latent indicators, say r
(I)
i , and write instead
p(Ii | r(I)i = k) = N(µ(I)k , σ(I)2k ) and p(r(I)i = k) = pi(I)k .
The r
(I)
i ’s can be interpreted as cluster membership indicators. We see then
how this formulation implicitly defines a probability model p(r(I)) on a partition
r(I) = (r
(I)
1 , . . . , r
(I)
n ). Two observations are clustered together if they are assigned
the same group-specific parameters θk = (µk, σ
2
k), where for brevity we now omit the
superscript (I). Recall the indicators r
(W )
i in (6). Without loss of generality assume
that r
(W )
i = 1 (symptoms due to other causes) for i = 1, . . . , n1, and r
(W )
i = 0 (symp-
toms due to disease), i = n1 + 1, . . . , n. Similar to p(r
(I)) we get a random partition
p(r
(S)
? ) induced by sampling from f ?S(·) for patients i = 1, . . . , n1. Analogously, for
patients i = n1 + 1, . . . , n we have a partition rS = (r
(S)
i , i = n1 + 1, . . . , n), with
r
(S)
i = r
(I)
i due to Si = Ii + Li. In words, under the proposed model, the clustering
structures r(S) and r
(S)
? for symptoms due to infection and for symptoms due to other
causes, respectively, are modeled separately and are independent. In fact, symptoms
due to infection inherit the clustering structure r(I), which is induced by the marginal
distribution for the infection times.
In order to cluster grouped data, other approaches have been proposed (Teh et al.,
2005; Rodriguez et al., 2008; Camerlenghi et al., 2019; Argiento et al., 2020). These
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strategies allow for the possibility of sharing atoms of the random probability mea-
sures across groups, thus borrowing information and yielding more precise inference.
However, the random partition is not the main inference target here and we shall
therefore not further explore such alternatives.
4.3 Regression on Covariates
We now add covariate effects in the proposed nonparametric model. In the context
of model (7) this takes the form of replacing H(I) and H(S) by families of random
probability measures (r.p.m). That is, we introduce a family {H(I)x ,x ∈ X}, and
similarly for H(S). Here x are patient specific covariates, and we replace H(I) and
H(S) by H
(I)
xi and H
(S)
xi for patient i in equation (7). Dropping for the moment the
superscript for easier exposition, let H = {Hx =
∑
k pixkδµxk ,x ∈ X} denote a family
of r.p.m.’s indexed by x. The most widely used class of priors on families like H
are dependent DP (DDP) models (MacEachern, 1999). A recent review appears in
Quintana et al. (2020). The DDP construction implies marginally for each Hx a
DP prior, and allows for the desired dependence across x. The definition of the
marginal DP implies that the µxk’s are independent across k and that the weights
have stick-breaking priors, but it does not restrict the distribution across x. This is
what the DDP construction exploits to borrow information across covariate values.
The DDP induces dependence across x through the atoms µxk and/or the weights pixk
of the marginal r.p.m.’s. In MacEachern (1999), dependence is induced by assuming
that, for fixed k, the atoms µxk are realizations of a Gaussian process, indexed by x.
Independence across k, together with the stick-breaking prior for the common weights
pik (not indexed by x), maintains the marginal DP prior on Hx. This instance of the
DDP model is known as “common weights DDP.” Alternative implementations are
possible, with dependent (across x) weights pixk and common atoms (“common atoms
DDP”), or the most general DDP model with dependent weights and atoms.
In the Partner Notification study the predictors are xi = {gender, arm, age} ∈
{0; 1}2×R+, i.e. two binary and one continuous covariate. We use a simple ANOVA
structure to induce dependence of µxk across x. DDP models with ANOVA-type
dependence across categorical factors are introduced as the ANOVA-DDP in De Iorio
et al. (2004) and then extended to continuous covariates in De Iorio et al. (2009).
The dependence structure of the random probability measures Hx is modeled by
constructing the atoms as µxk = δk + αkx1 + βkx2 + γkx3. The interpretation of the
linear model coefficients mk = (δk, αk, βk, γk)
ᵀ is exactly as in an ANOVA model,
inducing the desired dependence of Hx across x by sharing, for example, the same
βk for any two covariate vectors x and x
′ that share the same x2. Finally, using a
design vector di = (1, xi1, xi2, xi3)
ᵀ to select the desired ANOVA effects we can write
µxik = d
ᵀ
imk to get Hxi =
∑+∞
k=1 pikδdᵀmk . Defining θk = (mk, σ
2
k)
ᵀ to allow for a
14
mixture also with respect to the kernel variances, and defining one common mixing
measure
H(·) =
+∞∑
k=1
pikδθk
the marginal distribution fI(Ii | xi) can be rewritten equivalently as a DP mixture
of linear models, now using a single mixing measure H for all x (linear dependent
DDP, Jara et al., 2010). Also, we add back the superscripts (I) and (S) on the model
parameters:
fI(Ii | xi) =
∫
N(Ii|dᵀim(I), σ(I)2)dH(I)(θ(I)) with H(I) ∼ DP(M (I), H(I)0 ). (8)
Another instance of the same model is used for the marginal distribution of symptoms
due to other causes f ?S(Si | xi). The full model is
Ci | Si, λ = min{Si + Exp(λ); Unif(A,B)}
(Si, Ii) | θ(S),θ(I), w, λL ∼ fIS(I, S).
using (8) for fI and similarly for f
?
S. The complete model now defines a bivariate
BNP-CS survival regression. Using the stick-breaking representation, the DP
priors on H(I) and H(S) can be written as follows. Using superscripts E ∈ {I, S} to
refer to the construction of fI and f
?
S respectively, we have
{m(E)k , σ(E)2k }+∞k=1 iid∼ H(E)0 = N(m(E)k |m(E)0 ,Σ(E)0 )× IG(σ(E)2k | a(E)σ , b(E)σ )
pi(E) |M (E) ∼ SB(M (E)); M (E) ∼ Ga(aM , bM),
and λ ∼ Ga(aλ, bλ), λL ∼ Ga(aL, bL), w ∼ Beta(aw, bw).
For later reference we note that the random probability measures H(I)(θ(I)) and
H(S)(θ(S)) that serve as the mixing measure in (8) are multivariate distributions for
θ(I) = (m(I), σ(I)2)ᵀ = (δ(I), α(I), β(I), γ(I), σ(I)2)ᵀ, and similarly for θ(S). Let
H
(I)
β =
+∞∑
k=1
pi
(I)
k δβ(I)k
(9)
denote the implied univariate marginal for the ANOVA effect β(I). Analogous nota-
tion can be used for H
(S)
β and any of the other ANOVA effects. We will later use
inference on H
(E)
β , E ∈ {I, S}, to summarize inference on the treatment effect.
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5 Posterior Inference
To implement posterior inference under a Dirichlet process mixture model, the two
main strategies are marginal (Escobar and West, 1995; MacEachern and Mu¨ller, 1998;
Neal, 2000) and conditional (Ishwaran and James, 2001; Kalli et al., 2011) MCMC
posterior simulation. In our implementation, we employ the latter. In particular,
we rewrite the mixture model as a hierarchy by explicitly introducing the latent
cluster membership variables r(W ), r(I) and r
(S)
? . Moreover, we impute the latent
symptoms and infection times from their corresponding full conditionals. We use
efficient sampling for truncated normal distributions, originally proposed in Geweke
(1991). This allows us to use standard algorithms for inference under a DPM.
The total masses for the two random probability measures, M (I) and M (S), are
included in the MCMC scheme and assigned Gamma priors, as recommended in
Escobar and West (1995). Moreover, we put priors on the hyperparameters for the
base measures H
(I)
0 and H
(S)
0 . Additional details of the algorithm are deferred to
Section S.2 in the supplementary materials.
6 Partner Notification Study - Results
We apply the proposed model for inference in the Partner Notification study described
in Section 2. The primary inference goal is to understand the effect of covariates, in
particular treatment assignment, on the joint distribution of the two latent times
of interest. Furthermore, we are interested in assessing what factors drive time to
rehospitalization with infection and how time to symptoms onset of these cases can
improve such estimation.
Inference under the proposed model includes the full joint distribution of latent
times to symptoms and infection times. Figure 6 shows the posterior estimated dis-
tribution fIS(I, S) and the two components f
?
IS(I, S), f
′
IS(I, S) corresponding to a
‘baseline’ covariate combination (male, control group, median age). There is signifi-
cant probability mass in the lower triangle (S < I) that is not concentrated around
the 45◦ line but is quite spread out. Instead, for the constrained component (S > I)
the probability mass is concentrated very close to the 45◦ line. In other words, most
of the inferred symptoms times due to infection concentrate in I < S < I + 10. This
is coherent with the fact that we expect the symptoms due to the infection to follow
shortly after the disease onset.
To show the estimated covariate effects, we could compare density estimates for
different combinations of the predictors. Alternatively, we can report posterior es-
timates of the marginal distributions for the ANOVA effects, for example H
(E)
β ,
E ∈ {I, S} from (9). These are the univariate marginal distributions of the treatment
effect in the DDP model, and concisely summarize the change of bivariate survival
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Figure 6: Results: Posterior mean density estimate for f ?IS, f
′
IS and fIS corresponding
to the baseline covariate levels (male, control group, mean age). The green line
corresponds to the 45◦ line, i.e. I = S. The corresponding marginal distributions are
shown on the top and right side of the density plot.
distribution with respect to treatment versus control. The top center panel in Figure
7 shows the posterior estimated distributions E(H(I)β | data), and similarly for other
regression effects. Two significant effects can be detected. Importantly, the treatment
group seems to have delayed infection times, confirming what was found in an earlier
analysis in Sal y Rosas and Hughes (2011). Moreover, gender seems to have an effect
on the time to symptoms due to other causes, with women seeking early hospital
visits because of their symptoms. This might be simply due to the fact that women
are more aware of their symptoms and are more inclined to hospital visits, suggesting
that a health education campaign for men might improve their health outcome. Age
has also been found to have a weak effect: younger individuals have shorter infection
times, possibly due to their more risky behaviour.
Two parameters of the model, namely λL and λ, can give insights into how long
it takes for participants to develop symptoms and to seek a visit to the hospital. In
particular, the 95% credible interval for the exponential parameter λ is [0.70, 1.42],
suggesting that people seek re-hospitalization, on average, one day after they start
developing symptoms. Moreover, the 95% credible interval for the exponential param-
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Figure 7: Results: Estimated distributions Hα, Hβ and Hγ for the regression co-
efficients α (left), β (middle) and γ (right) under fI (top panels) and f
?
S (bottom
panels).
eter λL is [0.22, 0.80], which implies that patients develop symptoms due to infection,
on average, 2.5 days after the infection onset.
Inference includes an estimate for the proportion of patients that experience symp-
toms due to the infection, in our notation 1−w. The posterior mean of such proportion
is 17.72% (95% CI: [11.71%, 24.06%]). This is coherent with what we see empirically
in the data. There are more observed symptoms than observed infections, which im-
plies that most of the symptoms should be attributed to other causes. This finding
has important practical implications as it can help better planning for the treatment
of patients.
We compare with alternative inference under two independent linear dependent
Dirichlet process (LDDP) mixture of survival models for the marginal distributions
of infection and symptoms times. This method is described in De Iorio et al. (2009)
and implemented in the DPpackage (Jara et al., 2011). For a fair comparison, we used
the same prior specifications for the shared parameters under the two models. The
results are shown in Figure 8. Consistent results can be found across the two models.
For example, under the estimated models women have shorter time until symptoms
as measured by the distribution for the corresponding regression coefficient in Figure
7 and by the survival curve in Figure 8 (right). Unlike inference under the marginal
models, inference under the proposed bivariate model also shows an effect of the
treatment on the infection time. Patients in the intervention group have a delayed
re-infection time. The proposed model yields more interpretable results compared to
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Figure 8: Results: LDDP estimated survival curves for infection times (left panel)
and times until symptoms (right panel) corresponding to the possible combinations
of the binary covariates gender and treatment fixing the predictor age to the average
age in the sample.
the two independent LDDP models. In fact, under the latter models the probability
mass accumulates toward the bounds of the observed censoring times, yielding a “flat”
survival curve in the middle region (see Figure 8), exactly where we expect events to
happen. This shows that the prior shrinkage alone does not suffice for regularization,
and it is consistent with the observations of Section 3.1. In fact, most right censored
observations are imputed to the right of the rightmost censoring time, whereas most
left censored observations are imputed to the left of the leftmost censoring time.
7 Discussion
We proposed a novel Bayesian nonparametric bivariate survival regression model that
is especially suited for current status data (BNP-CS regression). This research was
motivated by the failure of available methods for such data formats. For example, we
showed that widely used nonparametric mixture priors lead to biologically uninter-
pretable results. Our model was built by incorporating simple structural dependence
assumptions in a linear dependent Dirichlet process mixture of survival models.
Applied to a recurrent infection study, the method provides novel insights into
how symptoms-related hospital visits are affected by covariates. Notably, we were
able to replicate previous results showing a significant effect of the intervention in the
randomized clinical trial under consideration. In particular, patients in the interven-
tion group have an improved outlook as measured by delayed reinfections. We also
detect an effect of age, with young people having earlier reinfections, which might be
due to more risky behaviours. Furthermore, we show that gender has a significant
effect on the time until symptoms, but not on infection times. Our study shows that
men seek hospital visits later compared to women, suggesting that investing in an
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awareness campaign could be beneficial.
The ideas presented in this article can be extended to different dependence struc-
tures. The present data called for a positive correlation between infection times and
infection-related symptom times. A similar model specification can be used for neg-
ative correlations. Once the marginal models are flexibly specified, one could for
example use copula models to construct a joint distribution with the desired depen-
dence structure. A similar approach, but with positive correlations, could be used for
general positively correlated event times when the assumptions used in this applica-
tion are not available.
Supplementary Materials
Supplementary materials present additional details. These include proofs of the theo-
rems, the MCMC scheme, convergence diagnostics and simulation studies. In separate
files, the supplementary materials additionally include the R programs implementing
the model developed in this article.
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Supplementary materials present proofs of the theorems illustrated in the main manuscript,
details of the MCMC algorithm we designed to sample from the posterior, convergence diag-
nostics of the model applied to the real data set and simulated experiments evaluating the
performance of the model framework presented in Section 4 in the main paper.
SUPPLEMENTARY MATERIALS S.2
S.1 Proofs of Lemma 1 and Theorem 1
Proof 1 (Lemma 1). Recall that
{C | S = s} = min{s+ Exp(λ); Unif(A,B)}.
Then, the inverse cumulative density function for the conditional distribution of censoring
times given the latent times is given by the survival function
F¯C|S(c) = P[min{s+ Exp(λ); Unif(A,B)} > c]
= P[s+ Exp(λ) > c; Unif(A,B) > c]
= P[s+ Exp(λ) > c] · P[Unif(A,B) > c]
=
B − c
B − A1(A,B)(c)
[
1{c ≤ s}+ e−λ(c−s)1{c > s}] .
The condition 1(A,B)(c) will be considered to be always true, and hence omitted, in the fol-
lowing. This is assured by choosing A and B such that they cover the observation range.
Therefore,
FC|S(c) =
(
1− B − c
B − A
)
1{c ≤ s}+
(
1− B − c
B − Ae
−λ(c−s)
)
1{c > s},
and by differentiation we get
fC|S(c) =
1
B − A1{c ≤ s}+
e−λ(c−s)
B − A {1 + λ(B − c)}1{c > s}.
Proof 2 (Theorem 1). We begin by calculating the marginal distribution for the infection
times as
fI(I) =
∫
fI,S(I, S)dS
= wfI(I) + (1− w)fI(I)
∫
fL(S − I)dS
= wfI(I) + (1− w)fI(I)
∫ +∞
I
λLe
−λ(S−I)dS = fI(I)
=
+∞∑
k=1
pi
(I)
k N(I | µ(I)k , σ(I)2k ).
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The marginal distribution for the symptoms times is
fS(S) =
∫
fI,S(I, S)dI
= wfS(S) + (1− w)
∫
fI(I)fL(S − I)dI
= wfS(S) + (1− w)
∫ S
−∞
fI(I)λLe
−λ(S−I)dI
= w
+∞∑
k=1
pi
(S)
k N(S | µ(S)k , σ(S)2k )+
(1− w)
+∞∑
k=1
pi
(I)
k λL exp
{
λL
2
(λLσ
2(I)
k + 2µ
(I)
k − 2S)
}
Φ
(
S − µ(I)k − λLσ(I)2k
σ
(I)
k
)
.
S.2 Details of the MCMC Scheme
S.2.1 Prior Hyper-parameters and MCMC Initializations
The parameters λ and λL were assigned Gamma priors λ ∼ Ga(aλ, bλ), λL ∼ Ga(aL, bL). The
hyperparameters were chosen to imply the 95% prior credible intervals for the latency times
to be [0.05, 9] days, yielding aλ = aL = 10, bλ = bL = 20. The proportion w of individuals
with symptoms due to other causes has a Beta(aw, bw) prior. The hyperparameters were
chosen so that aw = bw = 1, i.e. a uniform prior.
The total masses for the two random probability measures M (I) and M (S) are included
in the MCMC scheme and assigned Gamma priors, as recommended in Escobar and West
(1995). We use aM = 10, bM = 1 for both of them. Recall the base measures H
(E)
0 , E ∈
{I, S},
{m(E)k , σ(E)2k }+∞k=1 iid∼ H(E)0 = N(m(E)k |m(E)0 ,Σ(E)0 )× IG(σ(E)2k | a(E)σ , b(E)σ ).
We use vague priors for m0j
iid∼ Normal(0, 1002), Σ(E)0 = diag(σ20j)pj=1, σ20j iid∼ Inv-Ga(1, 1),
b
(E)
σ ∼ Ga(1, 1) ,whereas we fix a(E)σ = 1.
The initialization for the partitions of infection times and times until symptoms were ob-
tained by using a K-means algorithm on the censoring times, with K = 5. The group-specific
location and scale parameters were initialized to the corresponding maximum likelihood es-
timators. The remaining parameters were initialized from their priors.
The algorithm proves to be very robust to both the prior specification and to the initial-
ization.
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S.2.2 Posterior Computation
Posterior inference for the bivariate survival regression model, described in Section 4 in the
main paper, is based on a posterior Monte Carlo sample generated using a Gibbs sampler
simulation. In what follows, ζ denotes a generic variable that collects all other variables not
explicitly mentioned, including the data.
The algorithm imputes the latent times to symptoms and times to infection. Due to
space constraint in the table in Algorithm 2, we detail here how these parameters can be
sampled. The times until symptoms due to the infection are sampled from
p(Si | ζ) ∝ Exp(λL − λ)
∣∣Ci
Ii
if ∆Si = 1, r
(W )
i = 0
p(Si | ζ) ∝ Exp(λL)
∣∣+∞
max{Ci,Ii} if ∆Si = 0, r
(W )
i = 0.
Times until symptoms due to other causes are sampled from
p(Si | r(S)i? = k, ζ) ∝ N(µ(S)k , σ(S)2k )
∣∣Ci
−∞ if ∆Si = 1, r
(W )
i = 1
p(Si | r(S)i? = k, ζ) ∝ N(µ(S)k , σ(S)2k )
∣∣+∞
Ci
if ∆Si = 0, r
(W )
i = 1.
Times until infection are sampled from
p(Ii | r(I)i = k, ζ) ∝ N(µ(I)k + λσ(I)2k , σ(I)2k )
∣∣min{Ci,Si}
−∞ if ∆Ii = 1, r
(W )
i = 0
p(Ii | r(I)i = k, ζ) ∝ N(µ(I)k + λσ(I)2k , σ(I)2k )
∣∣Si
Ci
if ∆Ii = 0, r
(W )
i = 0
p(Ii | r(I)i = k, ζ) ∝ N(µ(I)k , σ(I)2k )
∣∣Ci
−∞ if ∆Ii = 1, r
(W )
i = 1
p(Ii | r(I)i = k, ζ) ∝ N(µ(I)k , σ(I)2k )
∣∣+∞
Ci
if ∆Ii = 0, r
(W )
i = 1.
As mentioned in the main manuscript, we use a truncated approximation to the infinite
mixture model. Let Kmax be the truncation level (in the following, we fix Kmax = 40). We
describe here the case without covariates, although the regression terms are straightforward
to include in the algorithm. We also do not include the update for the base measure hyper-
parameters as it consists of a simple normal full conditional. The sampler for the proposed
model of Section 4 comprises the steps outlined in Algorithm 2.
S.2.3 Software, Runtime, etc.
We programmed in R interfaced with C++. A total of 35000 MCMC iterations were run with
the initial 10000 iterations discarded as burn-in. The chain was subsequently thinned every
20 iterations.
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Algorithm 2 (Gibbs Sampler)
Updating the symptoms parameters
1: For i = 1, . . . , n, sample the latent times until symptoms Si as described in Section S.2.2.
2: For k = 1, . . . , Kmax, sample the group specific parameters µ
(S)
k , σ
(S)2
k as
µ
(S)
k | ζ ∼ p0(µ(S)k )
∏
i s.t.r
(S)
i? =k
p(Si | µ(S)k , σ(S)2k ), σ(S)2k | ζ ∼ p0(σ(S)2k )
∏
i s.t.r
(S)
i? =k
p(Si | µ(S)k , σ(S)2k ).
3: For i = 1, . . . , n1, sample the cluster membership indicators r
(S)
i? as
p(r
(S)
i? = k | ζ) ∝ pi(S)k N(Si | µ(S)k , σ(S)2k ).
4: For k = 1, . . . , Kmax, update the weights pi
(S)
k = V
(S)
k
∏
`<k(1 − V (S)` ), where Vk | ζ ∼
Beta(1 + n
(S)
k ,M
(S) −∑Kmax`=k+1 n(S)` ) and n(S)k = ∑i 1{r(S)i? = k}.
Updating the infection parameters
5: For i = 1, . . . , n, sample the latent infection times Ii as described in Section S.2.2.
6: For k = 1, . . . , Kmax, sample the group specific parameters µ
(I)
k , σ
(I)2
k as
µ
(I)
k | ζ ∼ p0(µ(I)k )
∏
i s.t.r
(I)
i =k
p(Ii | µ(I)k , σ(I)2k ), σ(I)2k | ζ ∼ p0(σ(I)2k )
∏
i s.t.r
(I)
i =k
p(Ii | µ(I)k , σ(I)2k ).
7: For i = 1, . . . , n, sample the cluster membership indicators r
(I)
i as
p(r
(I)
i = k | ζ) ∝ pi(I)k N(Ii | µ(I)k , σ(I)2k ).
8: For k = 1, . . . , Kmax, update the weights pi
(I)
k = V
(I)
k
∏
`<k(1 − V (I)` ), where Vk | ζ ∼
Beta(1 + n
(I)
k ,M
(I) −∑Kmax`=k+1 n(I)` ) and n(I)k = ∑i 1{r(I)i = k}.
Updating the global parameters
9: Update the dependent censoring parameter λ with a M-H transition probability using
the target distribution
p(λ | ζ) ∝ p0(λ)
∏
i s.t.∆Si=1
p(Ci | Si, λ).
10: Sample the indicator for dependent symptoms r
(W )
i | ζ ∼ Be(pi), where pi = p?i,1/(p?i,0 +
p?i,1), p
?
i,1 = w
∑+∞
k=1 pi
(S)
k N(Si | µ(S)k , σ(S)2k ), p?i,0 = (1− w)λe−λ(Si−Ii).
11: Sample the probability for dependent symptoms w | ζ ∼ Beta(aw +
∑
i r
(W )
i , bw + n −∑
i r
(W )
i ).
12: Sample the latency parameter λL | ζ ∼ Ga{aL +n−
∑
i r
(W )
i , bL +
∑
i s.t.r
(W )
i =0
(Si− Ii)}.
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The code is available as part of the supplementary materials. The MCMC algorithm
takes 10 minutes on a Macbook laptop with 8 Gb RAM. A ‘readme’ file providing additional
implementation details is also included in the supplementary materials.
S.3 Convergence Diagnostics
This section presents some MCMC convergence diagnostics for the Gibbs sampler described
in Section S.2. The results presented here are obtained on the real data analysis.
The Geweke test (Geweke, 1991) for stationarity of the chains, which formally compares
the means of an early vs a later part of a Markov chain (by default the first 10% and
the last 50%), is also performed. If the samples were from the stationary distribution of the
chain, the two means are equal and Geweke’s statistic has an asymptotically standard normal
distribution. We perform the Geweke test to assess convergence using the global parameters,
i.e. those that are not affected by label switching. Both the exponential parameters λ and
λL as well as the proportion of patients with symptoms due to other causes w, have very
stable traceplots (see Figure S.1) and fail to reject the null hypothesis of stationarity of the
corresponding chains.
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Figure S.1: Trace plots of the exponential parameters λ and λL. In each panel, the solid red
line shows the running mean.
S.4 Simulation Studies
In this section, we discuss the results of some simulated numerical experiments. In designing
the simulation scenarios, we have tried to closely mimic our recurrent infection dataset.
We thus chose n ∈ {250, 1000} participants being followed in the time window [A,B] =
[0, 200]. We also simulate two covariates: a binary X1 and a continuous X2. The underlying
distribution for the infection times is a mixture of two linear models with weights pi(I) =
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(0.6, 0.4)ᵀ, location parameters m(I) = [m
(I)
1 m
(I)
2 ] = ((40,−5, 0)ᵀ, (100,−10,−15)ᵀ) and
scale parameters
σ(I)2 = (102, 102)ᵀ. The distribution for the symptom times due to other causes is a
mixture of two linear models with weights pi(S) = (0.4, 0.6)ᵀ, location parameters m(S) =
[m
(S)
1 m
(S)
2 ] = ((70, 0, 20)
ᵀ, (110,−5, 0)ᵀ) and scale parameters σ(S)2 = (102, 202)ᵀ. Figure
S.2 shows the results when the proportion of patients with symptoms due to other causes
is w = 0.75. In this simulation, the latency time parameter between infection times and
symptom times λL as well as the dependent censoring parameter λ are chosen to be 0.2.
As one can see in Figure S.2 the underlying true bivariate density is recovered well by our
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Figure S.2: Results for simulated data: Posterior mean density estimate for f ?IS, f
′
IS and fIS
corresponding to the baseline covariate levels. The green line is the 45◦ line I = S. The
corresponding marginal distributions are shown on the top and right side of the density plot.
The white points are a sample of the true latent times corresponding to the same covariate
levels.
method. Estimates for other relevant parameters are not reported here, but were also very
accurate.
We show how the proposed model compares with two independent ANOVA-DDP models
for the marginal distributions in a variety of scenarios. In particular, we design three studies
when the simulated data have the following features: (I) independent censoring (λ ≈ 0)
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and dependent symptoms (w = 0.5), (II) dependent censoring (λ = 0.2) and independent
symptoms (w = 1), and (III) dependent censoring (λ = 0.2) and dependent symptoms
(w = 0.5). All the other parameters are kept fixed as described above.
To evaluate model performance, we measure how well the models are able to recover the
functional form of the survival curves for the two marginal distributions. In particular, we
use the mean integrated squared error (MISE). The MISE for estimating f(t) by fˆ(t) is
defined as
MISE = E
[∫ {
f(t)− fˆ(t)
}2
dt
]
We estimate the MISE by averaging the estimated integral across D simulated data sets as
MISEest =
1
D
∑D
d=1
∑N
i=1 ∆i{f(ti)− fˆ (d)(ti)}2, where ∆i = ti − ti−1, {ti}Ni=1 are a set of grid
points on the range of the data and fˆ (d) is the estimated function of interest for data set d.
In Table S.1, the reported estimated MISEs are based on D = 50 simulated data sets. This
simulation shows how the proposed model outperforms the marginal ANOVA-DDP models
by exploiting the dependence structure of the data under a wide variety of data generating
mechanisms.
Simulation Sample Size Distribution De Iorio et al. Our method
(I)
n = 250
Inf. 1.64 (0.92, 3.01) 1.10 (0.09, 2.24)
Sym. 2.98 (1.11, 5.01) 1.33 (0.18, 3.72)
n = 1000
Inf. 1.32 (0.73, 1.90) 0.50 (0.04, 1.80)
Sym. 2.32 (1.19, 3.25) 1.30 (0.54, 2.66)
(II)
n = 250
Inf. 0.96 (0.74, 1.56) 0.99 (0.13, 2.07)
Sym. 8.44 (5.21, 12.30) 0.76 (0.22, 2.16)
n = 1000
Inf. 0.80 (0.50, 1.10) 0.19 (0.05, 0.50)
Sym. 8.18 (6.28, 10.32) 0.12 (0.02, 0.37)
(III)
n = 250
Inf. 4.45 (3.00, 6.30) 0.45 (0.08, 1.14)
Sym. 9.82 (6.70, 13.20) 0.24 (0.03, 0.81)
n = 1000
Inf. 4.10 (3.18, 4.96) 0.13 (0.01, 0.35)
Sym. 9.94 (8.44, 11.71) 0.05 (0.01, 0.15)
Table S.1: Results for simulated data: Estimated median integrated squared error (MISEest)
performance of the survival regression model described in Section 4 compared with the
method of De Iorio et al. (2009). We have reported here the MISE values for estimating
the two marginal distributions (infection and symptoms, respectively) corresponding to the
baseline covariate levels. In parenthesis, the 95% credible intervals for the MISE values are
reported. When a method significantly outperforms the other, the corresponding MISE value
is highlighted in bold.
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